Grants per year
Personal profile
Training Experience
| 2009 | Residency, Rush University Medical Center |
| 2012 | Fellowship, Rush University Medical Center |
Education/Academic qualification
MS, Rush University
… → 2012
MD, University of Western Ontario
… → 2006
Fingerprint Dive into the research topics where Reem Karmali is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 20 Similar Profiles
Lymphoma
Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse
Medicine & Life Sciences
Cell Transplantation
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Follicular Lymphoma
Medicine & Life Sciences
B-Cell Lymphoma
Medicine & Life Sciences
Mantle-Cell Lymphoma
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2013 2024
Prot #JCAR017-BCM-003: A Global Randomized Multicenter Phase 3 Trial to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects with High-Risk, Transplant-Eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas (TR
ICON Clinical Research, LLC, Celgene Corporation
10/21/19 → 10/21/22
Project: Research project
Prot #NEER-01: Network for Enigmatic Exceptional Responders to Cancer Treatment - The Cure is NEER
Takeda Pharmaceuticals U.S.A., Inc., Millennium Pharmaceuticals, Inc
6/12/19 → 6/12/22
Project: Research project
Prot #GC-LTFU-001: Long-term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells
ICON Clinical Research, LLC, Celgene Corporation
1/8/19 → 1/8/22
Project: Research project
Research Output 2008 2019
Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of origin
Badar, T., Hamadani, M., Bachanova, V., Maddocks, K. J., Umyarova, E., Chavez, J. C., Epperla, N., Chhabra, S., Xavier, A. C., Karmali, R., Salhab, M., Reddy, N., Glenn, M. J., Hernandez-Ilizaliturri, F. J., Flowers, C. R., Evens, A. M., Zhou, Z., Lansigan, F., Barta, S. K., Cohen, J. B. & 2 others, , Mar 21 2019, In : Leukemia and Lymphoma. 60, 4, p. 940-946 7 p.Research output: Contribution to journal › Article
Lymphoma, Large B-Cell, Diffuse
Treatment Failure
Drug Therapy
B-Lymphocytes
Ifosfamide
Evaluation of the impact of cachexia on clinical outcomes in aggressive lymphoma
Burkart, M., Schieber, M., Basu, S., Shah, P., Venugopal, P., Borgia, J. A., Gordon, L. I. & Karmali, R., Jul 1 2019, In : British Journal of Haematology. 186, 1, p. 45-53 9 p.Research output: Contribution to journal › Article
Cachexia
Lymphoma
Insulin-Like Growth Factor Binding Protein 6
Sarcopenia
Lymphotoxin-alpha
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2
Godfrey, J. K., Nabhan, C., Karrison, T., Kline, J. P., Cohen, K. S., Bishop, M. R., Stadler, W. M., Karmali, R., Venugopal, P., Rapoport, A. P. & Smith, S. M., Jun 1 2019, In : Cancer. 125, 11, p. 1830-1836 7 p.Research output: Contribution to journal › Article
B-Cell Lymphoma
Lymphoma
Maximum Tolerated Dose
Vincristine
Prednisone
Revving up the immune engine in cHL
Karmali, R. & Gordon, L. I., Jul 4 2019, In : Blood. 134, 1, p. 1-2 2 p.Research output: Contribution to journal › Review article
Stem Cell Transplantation
Cell death
Stem cells
Hodgkin Disease
Consolidation
Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status
Behdad, A., Boddy, C. S., Fought, A. J., Taxter, T., Falkiewicz, M. K., Ayers, E., Chen, Q. C., Chen, Y-H., Karmali, R., Pro, B., Winter, J. N., Landsburg, D. J., Gordon, L. I. & Kaplan, J. B., Jan 1 2019, In : Leukemia and Lymphoma.Research output: Contribution to journal › Article
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Lymphoma